Literature DB >> 8262709

Diagnostic methods and treatment modalities of dry eye conditions.

F J Holly1.   

Abstract

One may view dry eye conditions as a group of diseases in which the ocular surface is adversely affected. Tear film instability invariably leads to some degree of cellular surface damage over the cornea and conjunctiva. In turn, ocular epitheliopathy may adversely affect tear film stability. The clinical presentation of the disease may not yield a clue as to its etiology. In recent years considerable progress was made both in the diagnosis and the treatment of the disease and promising studies are planned or are underway. The diagnostic techniques can be divided into four groups. The first is concerned with the clinical presentation. The second is concerned with the bulk properties of the aqueous tears including dynamic characteristics, composition, and colligative properties. The third is tear-film related and includes the film break-up time, evaporation rate, and lipid abnormality. The fourth is concerned with the ocular surface and includes vital staining, impression cytology, and surface microscopy. The most promising attempts are being made in the second group by attempting to elucidate the role of enzyme and enzyme activator activity and inhibitor contents as well as the tear protein profiles and correlating them with the specific disease states. The treatment modalities belong to three major groups aside from surgical intervention; the supplementation, preservation, and the stimulation of tears. The modern version of tear supplementation is expected to include the topical use of efficacious aqueous formulations that typically contain film stabilizing polymers, nutrients, and/or--in the future--biochemically active ingredients such as enzyme activators and inhibitors.

Entities:  

Mesh:

Year:  1993        PMID: 8262709     DOI: 10.1007/bf00942924

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  32 in total

1.  Physical chemistry of the normal and disordered tear film.

Authors:  F J Holly
Journal:  Trans Ophthalmol Soc U K       Date:  1985

2.  Surface phenomena of tear films.

Authors:  J E McDonald
Journal:  Trans Am Ophthalmol Soc       Date:  1968

3.  Factors affecting tear film breakup in normal eyes.

Authors:  M A Lemp; J R Hamill
Journal:  Arch Ophthalmol       Date:  1973-02

4.  Evaporation rate of water from the precorneal tear film and cornea in the rabbit.

Authors:  S Iwata; M A Lemp; F J Holly; C H Dohlman
Journal:  Invest Ophthalmol       Date:  1969-12

5.  Effect of fluorescein instillation on the pre-corneal tear film stability.

Authors:  L S Mengher; A J Bron; S R Tonge; D J Gilbert
Journal:  Curr Eye Res       Date:  1985-01       Impact factor: 2.424

6.  Ocular surface impressions using cellulose acetate filter material. Ocular pemphigoid.

Authors:  J D Nelson
Journal:  Surv Ophthalmol       Date:  1982 Jul-Aug       Impact factor: 6.048

7.  Osmolarity of tear microvolumes in keratoconjunctivitis sicca.

Authors:  J P Gilbard; R L Farris; J Santamaria
Journal:  Arch Ophthalmol       Date:  1978-04

8.  A simple conjunctival biopsy.

Authors:  P R Egbert; S Lauber; D M Maurice
Journal:  Am J Ophthalmol       Date:  1977-12       Impact factor: 5.258

9.  Increased tear evaporation in eyes with keratoconjunctivitis sicca.

Authors:  M Rolando; M F Refojo; K R Kenyon
Journal:  Arch Ophthalmol       Date:  1983-04

10.  In vivo specular microscopy of edematous human corneal epithelium with light and scanning electron microscopic correlation.

Authors:  L E Lohman; G N Rao; R C Tripathi; B J Tripathi; J V Aquavella
Journal:  Ophthalmology       Date:  1982-06       Impact factor: 12.079

View more
  2 in total

Review 1.  The Meibomian puzzle: combining pieces together.

Authors:  Igor A Butovich
Journal:  Prog Retin Eye Res       Date:  2009-08-04       Impact factor: 21.198

2.  Dry eye and tear film functions in patients with psoriasis.

Authors:  Young Her; Ji Won Lim; Sang Hak Han
Journal:  Jpn J Ophthalmol       Date:  2013-03-23       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.